Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thompson's Parting Shot: HHS Should Be Able To "Negotiate"

This article was originally published in The Pink Sheet Daily

Executive Summary

HHS Secretary Tommy Thompson's last words during a press conference announcing his resignation may resonate for months to come during the Medicare Rx benefit implementation process

You may also be interested in...



Former HHS Secretary Thompson Sharpens Call For Medicare Negotiating Power

Thompson points to the VA's success in securing favorable drug pricing in explaining why he opposes the Medicare law's "non-interference" clause. Congress should revisit Medicare, although other health issues are higher priorities, he says.

Former HHS Secretary Thompson Sharpens Call For Medicare Negotiating Power

Thompson points to the VA's success in securing favorable drug pricing in explaining why he opposes the Medicare law's "non-interference" clause. Congress should revisit Medicare, although other health issues are higher priorities, he says.

Leavitt Backs Market Approach For Medicare Rx

HHS Secretary nominee Michael Leavitt affirmed his commitment to free market principles in the Medicare drug benefit while appearing before a Senate committee Jan. 18

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel